Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:41 pm Sale | 2025-03-31 | 13G | Cresco Labs Inc. CRLBF | NOMURA HOLDINGS INC | 11,292,268 3.400% | -5,299,848 (-31.94%) | Filing History |
| 2025-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Cresco Labs Inc. CRLBF | Eminence Capital, LP | 17,753,792 6.300% | 17,753,792 (New Position) | Filing History |
| 2024-11-14 4:32 pm Sale | 2024-09-30 | 13G | Cresco Labs Inc. CRLBF | NOMURA HOLDINGS INC | 16,592,116 5.000% | -7,706,070 (-31.71%) | Filing History |
| 2024-02-16 4:33 pm Purchase | 2024-02-09 | 13D | Cresco Labs Inc. CRLBF | Cresco Labs Inc. | 269,739,574 20.000% | 2,312,184 (+0.86%) | Filing |
| 2024-02-16 4:28 pm Sale | 2024-02-09 | 13D | Cresco Labs Inc. CRLBF | Cresco Labs Inc. | 267,427,390 19.900% | -6,324,619 (-2.31%) | Filing |
| 2024-02-16 4:22 pm Sale | 2024-02-16 | 13G | Cresco Labs Inc. CRLBF | Cresco Labs Inc. | 273,752,009 20.200% | -134,011,000 (-32.86%) | Filing |
| 2024-02-14 5:42 pm Purchase | 2024-02-14 | 13G | Cresco Labs Inc. CRLBF | Cresco Labs Inc. | 407,763,009 30.200% | 207,471,445 (+103.58%) | Filing |
| 2024-02-14 5:34 pm Sale | 2024-02-14 | 13G | Cresco Labs Inc. CRLBF | Cresco Labs Inc. | 200,291,564 14.900% | -772,826 (-0.38%) | Filing |
| 2024-02-14 5:26 pm Purchase | 2024-02-14 | 13G | Cresco Labs Inc. CRLBF | Cresco Labs Inc. | 201,064,390 15.000% | 201,064,390 (New Position) | Filing |
| 2024-02-14 10:49 am Purchase | 2023-12-31 | 13G | Cresco Labs Inc. CRLBF | NOMURA HOLDINGS INC | 24,298,186 7.600% | 24,298,186 (New Position) | Filing History |
| 2024-02-02 12:18 pm Sale | 2023-12-29 | 13G | Cresco Labs Inc. CRLBF | Cowen Financial Products LLC | 0 0.000% | -19,170,307 (Position Closed) | Filing |
| 2023-01-23 3:33 pm Purchase | 2022-12-30 | 13G | Cresco Labs Inc. CRLBF | Cowen Financial Products LLC | 19,170,307 6.820% | 5,023,971 (+35.51%) | Filing |
| 2022-02-14 5:30 pm Purchase | 2021-12-31 | 13G | Cresco Labs Inc. CRLBF | Sampson Robert M | 200,680,159 15.500% | 200,680,159 (New Position) | Filing |
| 2022-02-14 5:08 pm Purchase | 2021-12-31 | 13G | Cresco Labs Inc. CRLBF | Bachtell Charles Ian | 405,891,486 31.200% | 405,891,486 (New Position) | Filing |
| 2022-02-14 5:05 pm Purchase | 2021-12-31 | 13G | Cresco Labs Inc. CRLBF | Sergi Dominic | 200,000,000 15.400% | 200,000,000 (New Position) | Filing |
| 2022-01-20 4:06 pm Purchase | 2021-12-31 | 13G | Cresco Labs Inc. CRLBF | Cowen Financial Products LLC | 14,146,336 5.590% | 5,284,718 (+59.64%) | Filing |
| 2021-03-31 3:55 pm Purchase | 2021-03-25 | 13G | Cresco Labs Inc. CRLBF | Cowen Financial Products LLC | 8,861,618 5.001% | 8,861,618 (New Position) | Filing |